Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Liquid biopsy-based genomic risk score to predict neurologic death in non-small cell lung cancer patients.
Journal: Journal of neuro-oncology
Published: March 22, 2026
Genomic Signature for Initial Brain Metastasis Velocity (iBMV) in Non-Small-Cell Lung Cancer Patients: The Elusive Biomarker to Predict the Development of Brain Metastases?
Journal: Cancers
Published: February 06, 2025
External validation of a genomic signature for oligometastatic non-small cell lung cancer.
Journal: Journal of radiosurgery and SBRT
Published: October 14, 2024
Genomic signature for oligometastatic disease in non-small cell lung cancer patients with brain metastases.
Journal: Frontiers in endocrinology
Published: January 04, 2024
Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases.
Journal: Frontiers in oncology
Published: April 28, 2023
Collagen deposition within brain metastases is associated with leptomeningeal failure after cavity-directed radiosurgery.
Journal: Neuro-oncology advances
Published: February 15, 2023
Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy.
Journal: NPJ precision oncology
Published: October 17, 2022
Local control outcomes for combination of stereotactic radiosurgery and immunotherapy for non-small cell lung cancer brain metastases.
Journal: Journal of neuro-oncology
Published: November 28, 2021
Upfront immunotherapy leads to lower brain metastasis velocity in patients undergoing stereotactic radiosurgery for brain metastases.
Journal: Journal of radiosurgery and SBRT
Published: October 07, 2021
Brain metastasis prognostic nomograms and brain metastasis velocity: a narrative review.
Journal: Chinese clinical oncology
Published: July 29, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026